Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants.

International journal of molecular sciences - 10 Jul 2020

Kang Hee-Ju, Kim Ki-Tae, Yoo Kyung-Hun, Park Yoomi, Kim Ju-Wan, Kim Sung-Wan, Shin Il-Seon, Kim Ju Han, Kim Jae-Min

Abstract excerpt

Planning subsequent treatment strategies based on early responses rather than waiting for delayed antidepressant action can be helpful. We identified genetic markers for later non-remission in patients exhibiting poor early improvement using whole-exome sequencing data of depressive patients treated in a naturalistic manner. Among 1000 patients, early improvement at 2 weeks (reduction in Hamilton Depression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Depressive Disorder, Major

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Markers

Share to Genetic Variation

Share to Remission Induction

Share to Signal Transduction

Share to Treatment Outcome

Source

Open in PubMed Open full text

Identifiers

PMID: 32664413
DOI: 10.3390/ijms21144884
PMCID: PMC7402334

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic Markers for Later Remission in Response to Early Improvement of Antidepressants.PMID 32664413Read ↗

Individualized Treatment Strategy for Depressive Disorder.Semantic proximity Read ↗

Genome-wide meta-analyses of non-response to antidepressants provide insights into underlying molecular genetics and suggest potential pharmacotherapies.Semantic proximity Read ↗

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotypingSemantic proximity Read ↗

A polygenic predictor of treatment-resistant depression using whole exome sequencing and genome-wide genotyping.Semantic proximity Read ↗

Pharmacogenomics-Driven Prediction of Antidepressant Treatment Outcomes: A Machine-Learning Approach With Multi-trial Replication.Semantic proximity Read ↗

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant responseSemantic proximity Read ↗

Sociodemographic, clinical, and genetic factors associated with self-reported antidepressant response outcomes in the UK BiobankSemantic proximity Read ↗

The MAKE Biomarker Discovery for Enhancing anTidepressant Treatment Effect and Response Study: Design and MethodologySemantic proximity Read ↗

New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation.Semantic proximity Read ↗

Early antidepressant efficacy modulation by glutamatergic gene variants in the STAR*D.Semantic proximity Read ↗

Pharmacogenetics studies in STAR*D: strengths, limitations, and results.Semantic proximity Read ↗

A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.